TET2 rs143309943: Understanding Clonal Hematopoiesis and Aging
The rs143309943 variant is a rare genetic alteration located within the TET2 gene. It has been identified in recent research as a potential marker associated with clonal hematopoiesis and processes related to cardiovascular aging.
What each genotype means
Typical TET2 genetic profile
This genotype represents the most common genetic sequence found at this location in the TET2 gene. It is not associated with the clonal hematopoiesis or cardiovascular aging risks linked to rare TET2 variants. No specific clinical action is indicated based on this result.
This is the predominant genotype observed in the general population across all ancestries.
Rare TET2 variant carrier
You carry one copy of this rare variant, which has been recently associated with clonal hematopoiesis and potential cardiovascular aging markers. Because this is a rare finding, its clinical significance for your individual health is not fully established and should be discussed with a healthcare provider. This result does not constitute a diagnosis of any blood disorder or cardiovascular condition.
This genotype is rare, occurring in less than 0.1% of most populations.
Rare TET2 variant homozygous
You carry two copies of this rare variant, which is linked in recent research to clonal hematopoiesis and cardiovascular aging. The clinical implications of carrying two copies are not well-defined in current literature, and you should consult with a physician or genetic counselor to interpret this in the context of your overall health. This finding is not a medical diagnosis.
This genotype is extremely rare, occurring in significantly less than 0.1% of the population.
What is the rs143309943 Variant?
The rs143309943 variant is a specific change in the DNA sequence of the TET2 gene. In genetics, a variant like this represents a single-nucleotide polymorphism or a rare mutation that differs from the most common sequence found in the human population. This specific variant is located within the coding region of the TET2 gene, which provides instructions for producing an enzyme that plays a critical role in regulating gene expression through DNA modification. Because this variant is rare, it is not found in the vast majority of the population. Researchers study such variants to understand how they might influence the function of the TET2 protein and whether they contribute to the development of specific health conditions as individuals age. By mapping these variants, scientists aim to build a clearer picture of the genetic architecture that underlies complex traits like cardiovascular health and the maintenance of blood cell production over time.
The Role of the TET2 Gene
The TET2 gene is essential for the proper regulation of DNA methylation, a process that acts like a chemical switch to turn genes on or off. By converting 5-methylcytosine to 5-hydroxymethylcytosine, the TET2 enzyme helps maintain the stability and identity of hematopoietic stem cells, which are the precursors to all blood cells. When the function of TET2 is altered, it can lead to a phenomenon known as clonal hematopoiesis of indeterminate potential (CHIP). In this state, a single hematopoietic stem cell acquires a mutation that gives it a competitive advantage, allowing it to proliferate and create a large population of blood cells that all carry the same genetic change. While this process is a normal part of aging, the expansion of these clones can sometimes lead to increased inflammation and has been linked to a higher risk of developing cardiovascular diseases, as the altered blood cells may interact differently with the lining of blood vessels.
Research and Evidence Strength
Current research into rs143309943 is emerging, with studies published as recently as 2024 highlighting its potential role in clonal hematopoiesis. The evidence linking this specific variant to cardiovascular aging is currently considered moderate, as it is a relatively new finding in the scientific literature. Most studies on TET2-related clonal hematopoiesis focus on the broader impact of somatic mutations—those acquired during a person's lifetime—rather than inherited germline variants. Because this variant is rare, large-scale population studies are required to confirm the exact effect size and clinical significance of carrying this specific allele. While the association between TET2 dysfunction and inflammatory pathways is well-documented, the specific contribution of rs143309943 to these pathways is still being actively investigated. Readers should view this information as a developing area of science rather than a definitive diagnostic tool for predicting future health outcomes.
Population Frequency
The rs143309943 variant is classified as rare, with an allele frequency of less than 0.1% across most global populations. Because it is so uncommon, it is not typically included in standard genetic screening panels, and its presence is usually only identified through specialized sequencing efforts or large-scale genomic research projects.
What This Information Means for You
If you have encountered this variant in a genetic report, it is important to understand that it does not constitute a medical diagnosis. Genetic variants are only one piece of a much larger puzzle that includes lifestyle, environment, and other genetic factors. Because the research on rs143309943 is still in its early stages, the clinical implications for an individual are not fully understood. You cannot use this information to predict specific health outcomes or to guide medical treatment on your own. If you are concerned about your cardiovascular health or the results of a genetic test, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can help you interpret these findings in the context of your overall health history and provide guidance on appropriate screening or preventative measures that are supported by established medical guidelines.
How common is this variant?
The rs143309943 variant is rare, appearing in less than 0.1% of the population across most ancestral groups.
Frequently asked questions
What is clonal hematopoiesis?
Clonal hematopoiesis is a condition where a single blood-forming stem cell acquires a mutation and begins to produce a large number of descendant cells. It is common in older adults and is sometimes associated with an increased risk of cardiovascular disease.
Is rs143309943 a disease-causing mutation?
The variant is associated with biological processes like clonal hematopoiesis, but it is not a direct cause of disease. It is a genetic marker that researchers are studying to understand its potential influence on health as people age.
Should I be worried if I have this variant?
Finding a rare variant does not mean you will develop a health condition. Genetic factors are complex, and you should discuss any concerns with a doctor who can evaluate your overall health and family history.
How can I get tested for this variant?
This variant is not typically included in standard commercial genetic tests. It is usually identified through clinical research or specialized medical sequencing ordered by a specialist.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs143309943?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29